These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 18412252)

  • 21. Gait variability as digital biomarker of disease severity in Huntington's disease.
    Gaßner H; Jensen D; Marxreiter F; Kletsch A; Bohlen S; Schubert R; Muratori LM; Eskofier B; Klucken J; Winkler J; Reilmann R; Kohl Z
    J Neurol; 2020 Jun; 267(6):1594-1601. PubMed ID: 32048014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in striatal dopamine D2 receptor binding in pre-clinical Huntington's disease.
    van Oostrom JC; Dekker M; Willemsen AT; de Jong BM; Roos RA; Leenders KL
    Eur J Neurol; 2009 Feb; 16(2):226-31. PubMed ID: 19138335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Huntington chorea. Molecular genetic principles, mutation detection and predictive diagnosis].
    Zühlke C; Thies U
    Nervenarzt; 1996 Jan; 67(1):25-35. PubMed ID: 8676985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of Huntington's disease decades before diagnosis: the Predict-HD study.
    Paulsen JS; Langbehn DR; Stout JC; Aylward E; Ross CA; Nance M; Guttman M; Johnson S; MacDonald M; Beglinger LJ; Duff K; Kayson E; Biglan K; Shoulson I; Oakes D; Hayden M;
    J Neurol Neurosurg Psychiatry; 2008 Aug; 79(8):874-80. PubMed ID: 18096682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive changes in asymptomatic carriers of the Huntington disease mutation gene.
    Verny C; Allain P; Prudean A; Malinge MC; Gohier B; Scherer C; Bonneau D; Dubas F; Le Gall D
    Eur J Neurol; 2007 Dec; 14(12):1344-50. PubMed ID: 17941857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Weight loss in Huntington disease increases with higher CAG repeat number.
    Aziz NA; van der Burg JM; Landwehrmeyer GB; Brundin P; Stijnen T; ; Roos RA
    Neurology; 2008 Nov; 71(19):1506-13. PubMed ID: 18981372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Molecular analysis of the IT15 gene in 79 Spanish families with Huntington's disease: diagnostic confirmation and presymptomatic diagnosis].
    Sánchez A; Milà M; Castellví-Bel S; Calopa M; Genís D; Jiménez D; Estivill X
    Med Clin (Barc); 1997 May; 108(18):687-90. PubMed ID: 9324583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patterns of meiotic variability of the (CAG)n repeat in the Huntington disease gene.
    Lucotte G; Gérard N; Aouizérate A; Loirat F; Hazout S
    Genet Couns; 1997; 8(2):77-81. PubMed ID: 9219003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Late-onset Huntington's disease: a clinical and molecular study.
    James CM; Houlihan GD; Snell RG; Cheadle JP; Harper PS
    Age Ageing; 1994 Nov; 23(6):445-8. PubMed ID: 9231935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case report of exhibitionist behaviour revealing unsuspected Huntington's disease: a pitfall in forensic medicine.
    Mondon K; Beaufils E; Marqué A; de Toffol B; Constans T; Hommet C
    J Forensic Leg Med; 2008 Oct; 15(7):467-8. PubMed ID: 18761317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Usefulness of molecular testing in Huntington's disease.
    Wang V; Yeh TP; Chen CM; Yan SH; Soong BW
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Sep; 62(9):586-90. PubMed ID: 10502848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Update on genetics of Huntington's disease: availability of direct and accurate predictive test.
    Squitieri F; Campanella G; Hayden MR
    Ital J Neurol Sci; 1996 Jun; 17(3):185-7. PubMed ID: 8856407
    [No Abstract]   [Full Text] [Related]  

  • 33. Gait, balance, and falls in Huntington disease.
    Vuong K; Canning CG; Menant JC; Loy CT
    Handb Clin Neurol; 2018; 159():251-260. PubMed ID: 30482318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma neurofilament heavy chain levels in Huntington's disease.
    Wild EJ; Petzold A; Keir G; Tabrizi SJ
    Neurosci Lett; 2007 May; 417(3):231-3. PubMed ID: 17363167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Saccades in presymptomatic and early stages of Huntington disease.
    Blekher T; Johnson SA; Marshall J; White K; Hui S; Weaver M; Gray J; Yee R; Stout JC; Beristain X; Wojcieszek J; Foroud T
    Neurology; 2006 Aug; 67(3):394-9. PubMed ID: 16855205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fat-free mass and its predictors in Huntington's disease.
    Süssmuth SD; Müller VM; Geitner C; Landwehrmeyer GB; Iff S; Gemperli A; Orth M
    J Neurol; 2015 Jun; 262(6):1533-40. PubMed ID: 25904208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of attentional resources on gait performance in Huntington's disease.
    Delval A; Krystkowiak P; Delliaux M; Dujardin K; Blatt JL; Destée A; Derambure P; Defebvre L
    Mov Disord; 2008 Apr; 23(5):684-9. PubMed ID: 18175353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rate of caudate atrophy in presymptomatic and symptomatic stages of Huntington's disease.
    Aylward EH; Codori AM; Rosenblatt A; Sherr M; Brandt J; Stine OC; Barta PE; Pearlson GD; Ross CA
    Mov Disord; 2000 May; 15(3):552-60. PubMed ID: 10830423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diffusion tensor imaging in presymptomatic and early Huntington's disease: Selective white matter pathology and its relationship to clinical measures.
    Rosas HD; Tuch DS; Hevelone ND; Zaleta AK; Vangel M; Hersch SM; Salat DH
    Mov Disord; 2006 Sep; 21(9):1317-25. PubMed ID: 16755582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparing for preventive clinical trials: the Predict-HD study.
    Paulsen JS; Hayden M; Stout JC; Langbehn DR; Aylward E; Ross CA; Guttman M; Nance M; Kieburtz K; Oakes D; Shoulson I; Kayson E; Johnson S; Penziner E;
    Arch Neurol; 2006 Jun; 63(6):883-90. PubMed ID: 16769871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.